World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
99
Citations
56174
World Ranking
736
National Ranking
18

Medicine

D-Index
99
Citations
56199
World Ranking
8419
National Ranking
116

Mikael J. Pittet publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mikael J. Pittet sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 208 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mikael J. Pittet D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mikael J. Pittet sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 99 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Mikael J. Pittet is affiliated with the University of Geneva in Switzerland. Their research primarily spans the fields of medicine, immunology and microbiology, and biochemistry, genetics and molecular biology. Within these domains, their focus includes immunology, oncology, molecular biology, pulmonary and respiratory medicine, and cancer research.

The scientist's work emphasizes topics related to cancer immunotherapy and biomarkers, immune cells in cancer, immunotherapy and immune responses, immune cell function and interaction, single-cell and spatial transcriptomics, CAR-T cell therapy research, and epigenetics and DNA methylation.

Frequent co-authors in their publications include Ralph Weissleder, Rakesh K. Jain, Sara I. Pai, Olivier Michielin, and Dan G. Duda. Their research contributions are often published in venues such as bioRxiv (Cold Spring Harbor Laboratory), Immunity, Cell, Clinical Cancer Research, and Cancer Cell.

Some of the recent papers authored or co-authored by Mikael J. Pittet are:

  • Clinical relevance of tumour-associated macrophages (2022), Nature Reviews Clinical Oncology
  • CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers (2023), Science
  • COVID-19 diagnostics in context (2020), Science Translational Medicine
  • CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment (2021), Cell
  • A neutrophil response linked to tumor control in immunotherapy (2023), Cell

Best Publications

  • Understanding the tumor immune microenvironment (TIME) for effective therapy.

    Mikhail Binnewies;Edward W. Roberts;Kelly Kersten;Vincent Chan

  • Imaging in the era of molecular oncology

    Ralph Weissleder;Mikael J. Pittet

  • The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions

    Matthias Nahrendorf;Filip K. Swirski;Elena Aikawa;Lars Stangenberg

  • Identification of splenic reservoir monocytes and their deployment to inflammatory sites

    Filip K. Swirski;Matthias Nahrendorf;Martin Etzrodt;Martin Etzrodt;Moritz Wildgruber

  • The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide

    Sophie Viaud;Sophie Viaud;Fabiana Saccheri;Grégoire Mignot;Takahiro Yamazaki

  • Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata

    Filip K. Swirski;Peter Libby;Elena Aikawa;Pilar Alcaide

  • Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species.

    Rapolas Zilionis;Rapolas Zilionis;Camilla Engblom;Christina Pfirschke;Virginia Savova

  • Myocardial infarction accelerates atherosclerosis

    Partha Dutta;Gabriel Courties;Ying Wei;Florian Leuschner;Florian Leuschner

  • Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

    Antonella Sistigu;Takahiro Yamazaki;Erika Vacchelli;Kariman Chaba

  • Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo

    Mei Ling Chen;Mikaël J. Pittet;Leonid Gorelik;Leonid Gorelik;Richard A. Flavell

  • The spleen in local and systemic regulation of immunity

    Vincenzo Bronte;Mikael J. Pittet

  • TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy.

    Christopher B. Rodell;Sean P. Arlauckas;Michael F. Cuccarese;Christopher S. Garris

  • Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy

    Christina Pfirschke;Camilla Engblom;Steffen Rickelt;Virna Cortez-Retamozo

  • Monocytes: Protagonists of Infarct Inflammation and Repair After Myocardial Infarction

    Matthias Nahrendorf;Mikael J. Pittet;Filip K. Swirski

  • Therapeutic siRNA silencing in inflammatory monocytes in mice

    Florian Leuschner;Partha Dutta;Rostic Gorbatov;Tatiana I Novobrantseva

  • Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12.

    Christopher S. Garris;Sean P. Arlauckas;Rainer H. Kohler;Marcel P. Trefny

  • Clinical relevance of tumour-associated macrophages

    Unknown

  • Imaging macrophages with nanoparticles

    Ralph Weissleder;Matthias Nahrendorf;Mikael J. Pittet

  • The role of myeloid cells in cancer therapies

    Camilla Engblom;Christina Pfirschke;Mikael J. Pittet

  • Origins of tumor-associated macrophages and neutrophils

    Virna Cortez-Retamozo;Martin Etzrodt;Andita Newton;Philipp J. Rauch

  • Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes

    Pedro Romero;P. Rod Dunbar;Danila Valmori;Mikaël Pittet

Frequent Co-Authors

Ralph Weissleder
Ralph Weissleder Harvard University
Filip K. Swirski
Filip K. Swirski Icahn School of Medicine at Mount Sinai
Matthias Nahrendorf
Matthias Nahrendorf Harvard University
Pedro Romero
Pedro Romero University of Lausanne
Jean-Charles Cerottini
Jean-Charles Cerottini University of Lausanne
Daniel E. Speiser
Daniel E. Speiser University of Lausanne
Danila Valmori
Danila Valmori University of Nantes
Alfred Zippelius
Alfred Zippelius University Hospital of Basel
Philippe Guillaume
Philippe Guillaume University of Lausanne
Peter Libby
Peter Libby Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with healthcare professions that require specialized education and training. For those interested in expanding their knowledge and advancing their careers, understanding the available online degree options is essential.

Nurses looking to accelerate their path can explore nurse practitioner accelerated program options. These programs offer an efficient route to becoming a nurse practitioner, blending rigorous coursework with clinical experience.

Individuals without a nursing background may consider online ABSN programs for non nurses. These accelerated programs help non-nurses transition quickly into the nursing field, opening doors to immunology-related roles.

For those seeking shorter commitments, 12-month accelerated nursing programs provide a streamlined path to earning a Bachelor of Science in Nursing. These programs emphasize flexibility and speed without sacrificing quality.

Additionally, exploring the fastest and easiest LPN programs can be ideal for entry-level healthcare careers. Licensed Practical Nurses often support immunology research and clinical care under supervision.

Each pathway offers unique advantages depending on your career goals in immunology and healthcare, making online learning a practical option to gain relevant expertise efficiently.

Best Scientists Citing Mikael J. Pittet

Trending Scientists

Recently Published Articles